Pharmaceuticals in the EU

Current priority areas for the EU's Pharmaceutical Industry Policy include competitiveness and innovation, pricing and reimbursement policies, medicines availability and patients' access to information. These issues are addressed, amongst others, in the framework of the High Level Pharmaceutical Forum and through the implementation of the Transparency Directive 89/105/EEC.

FACT SHEETS

General Information

• Priorities for the Pharmaceutical Sector in the EU
• Key directives: The EU Transparency Directive in the Pharmaceuticals sector
• Future direction of EU policy: innovation
• Pharmaceuticals Unit: Contacts

Expand your business

• Funding opportunities in the EU pharmaceutical industry

Business with third countries

• The EU and International Cooperation in Pharmaceuticals

Legislation

• The Rules Governing Medicinal Products in the European Union